Quick Answer
Serina Therapeutics, Inc. reported Stockholders Equity of -$37.0 thousand for fiscal year 2025.
Serina Therapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$37.0K | -105.8% |
| 2024 | $641.0K | +102.0% |
| 2023 | -$32.29M | -87.6% |
| 2022 | -$17.21M | -45.5% |
| 2021 | -$11.83M | -131.3% |
| 2020 | -$5.12M | -330.7% |
| 2019 | $2.22M | -70.2% |
| 2018 | $7.45M | +2.3% |
| 2017 | $7.28M | +132.5% |
| 2016 | -$22.38M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.76M | +112.8% | -2.3% |
| June 30, 2025 | $1.80M | +111.0% | +5.9% |
| March 31, 2025 | $1.70M | +139.5% | +165.4% |
| December 31, 2024 | $641.0K | +102.0% | +104.7% |
| September 30, 2024 | -$13.77M | +50.0% | +15.8% |
| June 30, 2024 | -$16.36M | +26.2% | -279.7% |
| March 31, 2024 | -$4.31M | +88.1% | +86.7% |
| December 31, 2023 | -$32.29M | +14.5% | -17.3% |
- Serina Therapeutics, Inc. showed a decrease of -105.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, Serina Therapeutics, Inc.’s stockholders equity has grown by 99.8% (from -$22.38 million to -$37.0 thousand).
- The most recent figure is from Serina Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: